From: Osteoporosis management in Australian general practice: an analysis of current osteoporosis treatment patterns and gaps in practice
Number of patients (n = 25,188)
%
Any osteoporosis medicine
19,268
76.5%
Bisphosphonatea
11,684
46.4%
Denosumab
11,762
46.7%
Otherb
2673
10.6%
No record of osteoporosis medicine
5920
23.5%